Citation Impact
Citing Papers
Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation
2002 StandoutNobel
Photodynamic Therapy for Early Stage Bronchogenic Carcinoma
1996
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.
1995
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
1996
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
1996
The peroxisome proliferator activated receptor regulates malic enzyme gene expression.
1994
Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter
1995
Increased Photosensitivity in HL60 Cells Expressing Wild‐Type p53
1997
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 StandoutNature
Endobronchial photodynamic therapy for lung cancer
2006
Photodynamic Therapy
1998 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene
1999
The role of template-primer in protection of reverse transcriptase from thermal inactivation
2002
Interstitial photodynamic laser therapy in interventional oncology
2004
Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor
1997
ALA and its clinical impact, from bench to bedside
2007
cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPARγ
1995
Ligand-induced Peroxisome Proliferator-activated Receptor α Conformational Change
1997
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Prions and Neurodegenerative Diseases
1987 StandoutNobel
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
1988 StandoutNobel
Expression of the Peroxisome Proliferator-activated Receptor α Gene Is Stimulated by Stress and Follows a Diurnal Rhythm
1996
Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids
1993
PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN
1995
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists
1997
Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor α (PPARα) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice
1999
Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA
1997
THE EFFECTS OF PHOTODYNAMIC THERAPY USING DIFFERENTLY SUBSTITUTED ZINC PHTHALOCYANINES ON VESSEL CONSTRICTION, VESSEL LEAKAGE AND TUMOR RESPONSE
1993
Photodynamic therapy for cancer
2003 Standout
PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathwaysa
1996
DNA binding domain of Escherichia coli DNA polymerase I: identification of arginine-841 as an essential residue
1988
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
1998 StandoutNature
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
1994
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences
1999
Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)
1993
The Induction of Partial Resistance to Photodynamic Therapy by the Protooncogene BCL‐2
1996
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
1995
A Carboxyl-terminal Extension of the Zinc Finger Domain Contributes to the Specificity and Polarity of Peroxisome Proliferator-activated Receptor DNA Binding
1998
mTHPC‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients
2004
Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements.
1995
A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
1998
Evidence for Transcriptional Induction of the Liver Fatty-Acid-Binding-Protein Gene by Bezafibrate in the Small Intestine
1995
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARα
1998
Cooperative Formation of Higher Order Peroxisome Proliferator-activated Receptor and Retinoid X Receptor Complexes on the Peroxisome Proliferator Responsive Element of the Rat Hydratase-Dehydrogenase Gene
1995
Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer
1997
Pyridoxal 5'-phosphate mediated inactivation of Escherichia coli DNA polymerase I: identification of lysine-635 as an essential residue for the processive mode of DNA synthesis
1988
[35] Role of activated oxygen species in photodynamic therapy
2000
Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver-X-receptor α
1998
DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements
1997
Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography
1998
Clinical Pharmacokinetics of the PDT Photosensitizers Porfimer Sodium (Photofrin), 2‐[1‐Hexyloxyethyl]‐2‐Devinyl Pyropheophorbide‐a (Photochlor) and 5‐ALA‐Induced Protoporphyrin IX
2006
Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs
1997
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
2004 StandoutNature
Differential Recognition of Target Genes by Nuclear Receptor Monomers, Dimers, and Heterodimers*
1994
Novel Sequence Determinants in Peroxisome Proliferator Signaling
1995
Photodynamic therapy in dermatology
2000
Fibrates Increase Human REV-ERBα Expression in Liver via a Novel Peroxisome Proliferator-Activated Receptor Response Element
1999
Roles of PPARs in health and disease
2000 StandoutNature
PHOTODYNAMIC THERAPY IN DERMATOLOGY
1996
Correlation of Subcellular and Intratumoral Photosensitizer Localization with Ultrastructural Features After Photodynamic Therapy
1996
5-Aminolevulinic acid-based photodynamic therapy
1997
Cellular Targets and Molecular Responses Associated with Photodynamic Therapy
1996
Scrapie prions aggregate to form amyloid-like birefringent rods
1983 StandoutNobel
Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling.
1993
Characterization of cloned cDNA representing rat myelin basic protein: Absence of expression in brain of shiverer mutant mice
1983 StandoutNobel
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
1993
Hormone-responsive expression of an endogenous proviral gene of mouse mammary tumor virus after molecular cloning and gene transfer into cultured cells.
1981
Integration, transcription, and control of a Drosophila heat shock gene in mouse cells.
1981 StandoutNobel
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Characterization of “early” temperature-sensitive mutants of avian sarcoma viruses: Biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells
1976
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Identification of residues critical for the polymerase activity of the Klenow fragment of DNA polymerase I from Escherichia coli.
1990 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Phosphonoformate Inhibits Reverse Transcriptase
1979
Protein-DNA Interactions at a Drug-responsive Element of the Human Apolipoprotein A-I Gene
1996
The use of single-stranded DNA and RNase H to promote quantitative ‘hybrid arrest of translation’ of mRNA/DNA hybrids in reticulocyte lysate cell-free translations
1986 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA
1977 StandoutNobel
Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription
1995
Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli.
1985
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid Physiology
1996
A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration.
1984 StandoutNobel
Complete sequence of constant and 3′ noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing
1978 StandoutNobel
The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats.
1994
On the fidelity of DNA replication. Effect of metal activators during synthesis with avian myeloblastosis virus DNA polymerase.
1977
Cloned mouse mammary tumor virus DNA is biologically active in transfected mouse cells and its expression is stimulated by glucocorticoid hormones
1981
Functional Purification and Enzymic Characterization of the RNA-dependent DNA Polymerase of Human Immunodeficiency Virus
1986
Replication of mouse mammary tumor virus in tissue culture
1977
Structure and processing of the mouse mammary tumor virus glycoprotein precursor pr73env
1980
Basic principles of photodynamic therapy
2001 Standout
Novel Proteinaceous Infectious Particles Cause Scrapie
1982 StandoutScienceNobel
On the mechanism of nucleotide incorporation into DNA and RNA
1975
Identification of a Protein That Purifies with the Scrapie Prion
1982 StandoutScienceNobel
3′ Non-coding region sequences in eukaryotic messenger RNA
1976 StandoutNature
Preparation of adsorbents for biospecific affinity chromatography
1974
Substrate Binding in Human Immunodeficiency Virus Reverse Transcriptase
1989
Regulated expression of human growth hormone genes in mouse cells
1982 StandoutNobel
Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
1995
Enzymatic in vitro synthesis of globin genes
1976
Evidence for Transcriptional Induction of the Liver Fatty‐Acid‐Binding‐Protein Gene by Bezafibrate in the Small Intestine
1995
Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy
2004
Reversible Chemical Modification of the Scrapie Agent
1981 StandoutScienceNobel
Liver Regeneration
1997 StandoutScience
Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
1996
A protease-resistant protein is a structural component of the Scrapie prion
1983 StandoutNobel
Structure of DNA Polymerase I Klenow Fragment Bound to Duplex DNA
1993 StandoutScienceNobel
Mammary Tumor Viruses
1979
The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.
1994
Purification and translation of murine mammary tumor virus mRNA's
1981 StandoutNobel
The energy relay: a proofreading scheme based on dynamic cooperativity and lacking all characteristic symptoms of kinetic proofreading in DNA replication and protein synthesis.
1980 StandoutNobel
Separation and properties of cellular and scrapie prion proteins.
1986 StandoutNobel
Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function.
1995
Ferrate oxidation of Escherichia coli DNA polymerase-I. Identification of a methionine residue that is essential for DNA binding.
1987
Sequence analysis of the 3′ non-coding regions of rabbit α- and β-globin messenger RNAs
1976
A cellular gene encodes scrapie PrP 27-30 protein
1985 StandoutNobel
Photodynamic therapeutics: basic principles and clinical applications
1999
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
1998
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
1998 StandoutNobel
Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
1996
Emerging Targets in Photopharmacology
2016 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.
1994
Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase
1978
Scrapie agent contains a hydrophobic protein.
1981
Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators
1995
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
1994
Metal chelate affinity chromatography, a new approach to protein fractionation
1975 StandoutNature
Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids.
1994
The p56 -interacting Protein p62 Stimulates Transcription via the SV40 Enhancer
1999
Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
1999
Sequencing of Combined Hyperthermia and Photodynamic Therapy
1996
Molecular Biology of Prion Diseases
1991 StandoutScienceNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
The regulated expression of β-globin genes introduced into mouse erythroleukemia cells
1983 StandoutNobel
RXR Agonists Activate PPARα-Inducible Genes, Lower Triglycerides, and Raise HDL Levels In Vivo
1998
Structural flexibility of the Gαs α-helical domain in the β 2 -adrenoceptor Gs complex
2011 StandoutNobel
Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4.
1994
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites
1978 StandoutNobel
Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.
1994
The reverse transcriptase
1977
Synthesis and Spectroscopic Properties of Novel Benzochlorins Derived from Chlorophyll a
1998
Complete nucleotide sequence of the AIDS virus, HTLV-III
1985 StandoutNature
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Identification of a transcriptionally active peroxisome proliferator-activated receptor α-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator
2002
Works of Stuart L. Marcus being referenced
Global status of clinical photodynamic therapy: The registration process for a new therapy
1992
Photodynamic therapy
1992
The Monitoring of ALA-Induced Protoporphyrin IX Accumulation and Clearance in Patients with Skin Lesions by In Vivo Surface-Detected Fluorescence Spectroscopy
1999
Clinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder Cancer
2002
Photodynamic Therapy (PDT) and Photodiagnosis (PD) Using Endogenous Photosensitization Induced by 5-Aminolevulinic Acid (ALA): Mechanisms and Clinical Results
1996
Resolution and characterization of intracytoplasmic forms of reverse transcriptase from Rauscher leukemia virus-producing cells
1978
Observations on template-specific conditions for DNA synthesis by avian myeloblastosis virus DNA polymerase
1976
The relative hydrophobicity of oncornaviral structural proteins
1978
Evidence for Allosterism in In Vitro DNA Synthesis on RNA Templates
1974
Reverse transcriptase-associated RNase H activity. II. Inhibition by natural and synthetic RNA
1978
Specific inhibition of DNA polymerase-associated RNase H by DNA
1977
Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression.
1993
Retroviral “terminal deoxynucleotidyl transferase” activity is reverse transcription
1978
Purification and properties of murine mammary tumor virus DNA polymerase
1976
The effect of magnesium and manganese ions on the structure and template activity for reverse transcriptase of polyribocytidylate and its 2'-o-methyl derivative
1977
Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase.
1992
Photodynamic therapy for Barrett's esophagus: a review
2002
Purification of Avian Myeloblastosis Virus DNA Polymerase by Affinity Chromatography on Polycytidylate-Agarose
1974
Use of affinity matrices in determining steric requirements for substrate binding: Binding of anthranilate 5-phosphoribosylpyrophosphate phosphoribosyltransferase from Salmonella typhimurium to sepharose-anthranilate derivatives
1972
Identification of the messenger RNAs coding for the gag and env gene products of the murine mammary tumor virus
1979
The mechanism of inorganic phosphate-mediated inhibition of calf thymus DNA polymerase β and Rauscher leukemia virus DNA polymerase
1982
DNA complementary to rabbit globin mRNA made by E. coli polymerase I
1973
Purification and properties of Rauscher leukemia virus DNA polymerase and selective inhibition of mammalian viral reverse transcriptase by inorganic phosphate.
1977